Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Loop Dx logo — Cell-mediated immune response diagnostics to predict sepsis...

Loop Dx

Cell-mediated immune response diagnostics to predict sepsis early, enabling timely treatment and saving lives.

Founded 2018 Spain Spain 12 employees Seed Total: $30.00K Health Care

General Information

Company Name Loop Dx
Founded Year 2018
Location Spain Spain
Founders / Decision Makers
Team member
Employees 12
Industries Health Care
Funding Stage Seed
Business Model B2B, D2C, B2D
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Loop Dx. To contact Loop Dx, visit loopdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Loop Dx compare?

A PDF of Loop Dx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Loop Dx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Loop Dx

Loop Dx is a pioneering Health Care startup based in Spain focused on creating innovative diagnostics to enhance early-stage sepsis detection. Founded in 2018, the company has developed the SeptiLoop, a CE IVDR Class C near-patient test, which leverages cell-mediated immune response diagnostics for timely sepsis treatment. This tool measures the functional response of a patient's innate immune system, providing critical data that allows clinicians to administer more targeted treatments well ahead of traditional methods.

Positioned strategically in the European market, SeptiLoop is one of the first new-generation in vitro diagnostic (IVD) tests approved under the IVDR Class C framework. The company is set to roll out commercially in the United Kingdom and the European Union, alongside conducting health economic validation and clinical utility studies in high-risk patient cohorts.

Loop Dx most recently secured a $30.00K Seed Round investment on 15 September 2020 from Health Wildcatters, indicating a promising investment landscape and the potential for impactful growth.

Business keywords: Cell-mediated immune response diagnostics, Sepsis detection, Rapid diagnostics, IVD company, Innate immune system analysis, Severe bacterial infection identification, Critical care diagnostics, Point-of-care testing, Antibiotic stewardship, Health economic validation, CE IVDR Class C compliance, Clinical utility in high-risk patients, Immunology, Sepsis management optimization, Healthcare innovation

Services & Products

Development of diagnostic tools for sepsis
Early detection of bloodstream infections

Target Customers

Healthcare providers Hospitals Clinical laboratories

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $30.00K 1
Health Wildcatters
Health Wildcatters
15 Sep 2020

Loop Dx Alternatives & Competitors

View All Alternatives
Loop Dx vs
Inflammatix, Inc.
Inflammatix, Inc. United States

We’re reimagining diagnostics by reading the immune system

Grant
96 employees
Big Data, Biotechnology
Compare Loop Dx vs Inflammatix, Inc.
Loop Dx vs
Cytovale
Cytovale United States

At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-medi...

Series C
121 employees
AI, Health Care
Compare Loop Dx vs Cytovale
Loop Dx vs
Astek Diagnostics
Astek Diagnostics United States

One-hour antibiotic sensitivity testing

Non Equity Assistance
14 employees
Health Care, Medical Devices
View all alternatives

FAQ About Loop Dx

Cell-mediated immune response diagnostics to predict sepsis early, enabling timely treatment and saving lives.
Loop Dx was founded in 2018.
Loop Dx is headquartered in Spain.
Loop Dx operates in Health Care. Its work centres on Cell-mediated immune response diagnostics, Sepsis detection, Rapid diagnostics and IVD company. Its customers include Healthcare providers, Hospitals and Clinical laboratories.
Loop Dx has a B2B, D2C and B2D business model. Its revenue comes from Product Sales, Service Fee and Licensing.
Loop Dx has approximately 12 employees.
Loop Dx has completed 1 funding round, raising a total of $30.00K. The latest funding stage is Seed.
Loop Dx offers: Development of diagnostic tools for sepsis, Early detection of bloodstream infections.
Top alternatives and competitors to Loop Dx include Inflammatix, Inc., Cytovale, Astek Diagnostics, Avails Medical, Inc., Aksense. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Loop Dx and Inflammatix, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Loop Dx, https://bouncewatch.com/company/loop-dx, updated 19 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout